Pharmaceutical drug analysis methodology - theory - instrumentation - pharmaceutical assays - cognote assays.
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Kaituhi rangatōpū: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
New Delhi :
New Age International (P) Ltd., Publishers,
2005.
|
| Putanga: | 2nd ed. |
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
Reviews in pharmaceutical and biomedical analysis
I whakaputaina: (2010)
I whakaputaina: (2010)
Flow injection analysis of pharmaceuticals automation in the laboratory /
mā: Martínez Calatayud, José
I whakaputaina: (1996)
mā: Martínez Calatayud, José
I whakaputaina: (1996)
Dielectric analysis of pharmaceutical systems
mā: Craig, Duncan Q. M.
I whakaputaina: (1995)
mā: Craig, Duncan Q. M.
I whakaputaina: (1995)
HPLC methods for recently approved pharmaceuticals
mā: Lunn, George
I whakaputaina: (2005)
mā: Lunn, George
I whakaputaina: (2005)
Specification of drug substances and products : development and validation of analytical methods /
I whakaputaina: (2014)
I whakaputaina: (2014)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
I whakaputaina: (2008)
I whakaputaina: (2008)
WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
I whakaputaina: (2007)
I whakaputaina: (2007)
Drug monitoring by HPLC recent developments /
mā: Samanidou, Victoria
I whakaputaina: (2010)
mā: Samanidou, Victoria
I whakaputaina: (2010)
Characterization of impurities and degradants using mass spectrometry
I whakaputaina: (2011)
I whakaputaina: (2011)
Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
mā: Willig, Sidney H., 1919-
I whakaputaina: (2000)
mā: Willig, Sidney H., 1919-
I whakaputaina: (2000)
Biomedical chromatography
I whakaputaina: (2010)
I whakaputaina: (2010)
Analytical method validation and instrument performance verification
I whakaputaina: (2004)
I whakaputaina: (2004)
Practical approaches to method validation and essential instrument performance verification
I whakaputaina: (2010)
I whakaputaina: (2010)
Handbook of LC-MS bioanalysis best practices, experimental protocols, and regulations /
I whakaputaina: (2013)
I whakaputaina: (2013)
The selection and use of essential medicines
I whakaputaina: (2006)
I whakaputaina: (2006)
Drug-drug interactions in pharmaceutical development
I whakaputaina: (2008)
I whakaputaina: (2008)
WHO Expert Committee on Biological Standardization fifty-sixth report.
I whakaputaina: (2007)
I whakaputaina: (2007)
WHO Expert Committee on Biological Standardization : sixtieth report /
I whakaputaina: (2013)
I whakaputaina: (2013)
Who Expert Committee on Biological Standardization : sixty-second report.
I whakaputaina: (2013)
I whakaputaina: (2013)
Pharmaceutical toxicology in practice a guide for non-clinical development /
I whakaputaina: (2011)
I whakaputaina: (2011)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
mā: Osmane, Malik
I whakaputaina: (2014)
mā: Osmane, Malik
I whakaputaina: (2014)
The greening of pharmaceutical engineering. practice, analysis, and methodology /
mā: Islam, Rafiqul, 1959-
I whakaputaina: (2015)
mā: Islam, Rafiqul, 1959-
I whakaputaina: (2015)
Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
Analysis of aggregates and particles in protein pharmaceuticals
I whakaputaina: (2012)
I whakaputaina: (2012)
Physiological pharmaceutics barriers to drug absorption /
mā: Washington, Neena, 1961-
I whakaputaina: (2001)
mā: Washington, Neena, 1961-
I whakaputaina: (2001)
Drug discovery and design medical aspects /
I whakaputaina: (2002)
I whakaputaina: (2002)
Target validation in drug discovery
I whakaputaina: (2006)
I whakaputaina: (2006)
Drugs and laboratory parameters
mā: Caputi, Achille Patrizio
I whakaputaina: (2010)
mā: Caputi, Achille Patrizio
I whakaputaina: (2010)
The war against counterfeit medicine my story /
mā: Akunyili, Dora Nkem
I whakaputaina: (2011)
mā: Akunyili, Dora Nkem
I whakaputaina: (2011)
Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)
mā: Zanders, Edward D.
I whakaputaina: (2016)
Computational pharmaceutics : application of molecular modeling in drug delivery /
I whakaputaina: (2015)
I whakaputaina: (2015)
Continuous processing in pharmaceutical manufacturing /
I whakaputaina: (2015)
I whakaputaina: (2015)
Mass spectrometry in sports drug testing characterization of prohibited substances and doping control analytical assays /
mā: Thevis, Mario, 1973-
I whakaputaina: (2010)
mā: Thevis, Mario, 1973-
I whakaputaina: (2010)
Pharmaceutical applications of polymers for drug delivery
mā: Jones, David
I whakaputaina: (2004)
mā: Jones, David
I whakaputaina: (2004)
Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)
I whakaputaina: (2011)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)
I whakaputaina: (2012)
Pharmaceuticals
I whakaputaina: (2012)
I whakaputaina: (2012)
Successfully marketing clinical trial results winning in the healthcare business /
mā: Umbach, Günter
I whakaputaina: (2006)
mā: Umbach, Günter
I whakaputaina: (2006)
Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
I whakaputaina: (2010)
I whakaputaina: (2010)
Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance /
mā: Turner, J. Rick
I whakaputaina: (2009)
mā: Turner, J. Rick
I whakaputaina: (2009)